today announced the appointments of Melissa Bradford-Klug, M.B.A., as Chief Financial Officer and Chief Business Officer and Sophie Jeannin, M.D., as Chief Medical Officer.
Melissa Bradford-Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical Officer Topline data from SEFA-1024 Phase 2a clinical ...
Melissa Bradford-Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical Officer Topline data from SEFA-1024 Phase 2a clinical trial ...
Melissa Bradford-Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical Officer Topline data from SEFA-1024 Phase 2a clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback